This free, one-day event helps you discover new opportunities, dive into the latest tools, and get the answers you need to move your projects forward, faster with Microsoft Cloud and AI.

With 200 founders and ecosystem leaders, world-class speakers and tailor-made formats, this is where ideas ignite and big things happen. For the first time, startups have the opportunity to register ...

A survey was conducted for the first time at Startup Days to gauge the mood in the startup scene. First, the good news: ...

Regenosca, a Lausanne based startup developing non-invasive regenerative tissue implants, has closed a CHF 1M pre-seed round from private investors, Business Angels Switzerland and Venture Kick. The ...

With its leasing software, LeaseTeq enriches the Swiss market with the first completely digital, bank-independent leasing offer. The Schwyz-based company raised CHF 8 million in a first closing of its ...

Recent startup challenges are offering new platforms for startups to showcase and advance their solutions. Elythor and Prometheus are competing for a €100,000 grand prize in the HelloTomorrow ...

RIVR, the ETH Spinoff developing hybrid mobility robots powered by artificial intelligence to learn and adapt to their surroundings, has closed its $22 million seed funding round led by Jeff Bezos ...

GlycoEra AG, a biotechnology company pioneering best-in-class extracellular protein degraders for the treatment of autoimmune diseases, closed an oversubscribed $130 million Series B financing. The ...

Spirecut, a Swiss MedTech company specializing in non-invasive surgical instruments for hand surgery, has completed its series A investment round to propel further growth. In addition to expanding its ...

DuraMon AG, the Zurich-based startup developing the world’s first precise and reliable structural health corrosion monitoring solutions for the construction industry, has completed its seed round, ...

TOLREMO therapeutics AG, the startup on a mission to prevent non-genetic cancer drug resistance, has dosed the first patient in its first-in-human clinical trial evaluating the safety and tolerability ...

Lebensmittel aus gezüchteten Zellkulturen werden als zukünftige Alternative zu solchen aus herkömmlicher Produktion gehandelt – etwa als umweltfreundlicheren Ersatz für Fleisch aus ...